John E. Hokanson
About
John E. Hokanson is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, John E. Hokanson has authored 213 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Pulmonary and Respiratory Medicine, 57 papers in Endocrinology, Diabetes and Metabolism and 49 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John E. Hokanson's work include Chronic Obstructive Pulmonary Disease (COPD) Research (73 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (46 papers) and Lipoproteins and Cardiovascular Health (31 papers). John E. Hokanson is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (73 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (46 papers) and Lipoproteins and Cardiovascular Health (31 papers). John E. Hokanson collaborates with scholars based in United States, United Kingdom and Netherlands. John E. Hokanson's co-authors include Melissa A. Austin, Edwin K. Silverman, James D. Crapo, Karen L. Edwards, Gregory L. Kinney, John D. Brunzell, Barry J. Make, Elizabeth A. Regan, Alberto Zambon and David A. Lynch and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.
In The Last Decade
John E. Hokanson
209 papers receiving 14.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| John E. Hokanson United States | 58 | 4.9k | 4.2k | 3.7k | 3.4k | 2.7k | 213 | 14.8k | ||
| Yaping Zhang China | 30 | 3.5k 0.7× | 4.3k 1.0× | 3.9k 1.1× | 6.9k 2.0× | 2.5k 0.9× | 200 | 28.3k | ||
| Ömer Toprak Türkiye | 14 | 4.6k 0.9× | 1.8k 0.4× | 2.7k 0.7× | 4.5k 1.3× | 3.3k 1.2× | 31 | 19.4k | ||
| Ziad A. Massy France | 69 | 1.8k 0.4× | 2.9k 0.7× | 3.9k 1.1× | 3.1k 0.9× | 2.5k 0.9× | 440 | 21.9k | ||
| Ian H. de Boer United States | 70 | 6.3k 1.3× | 1.8k 0.4× | 3.0k 0.8× | 3.7k 1.1× | 2.4k 0.9× | 325 | 19.8k | ||
| Stephan J. L. Bakker Netherlands | 75 | 4.5k 0.9× | 2.5k 0.6× | 3.2k 0.9× | 4.2k 1.2× | 4.2k 1.6× | 889 | 24.2k | ||
| Paul E. de Jong Netherlands | 73 | 4.4k 0.9× | 4.1k 1.0× | 3.2k 0.9× | 8.6k 2.5× | 2.0k 0.7× | 311 | 24.9k | ||
| Rijk O. B. Gans Netherlands | 62 | 3.8k 0.8× | 2.0k 0.5× | 2.2k 0.6× | 3.1k 0.9× | 2.3k 0.9× | 358 | 15.3k | ||
| Cihat Şarkış Türkiye | 6 | 4.6k 0.9× | 1.6k 0.4× | 2.6k 0.7× | 4.4k 1.3× | 3.3k 1.2× | 10 | 18.7k | ||
| Hüseyin Kurt Türkiye | 5 | 4.6k 0.9× | 1.6k 0.4× | 2.6k 0.7× | 4.4k 1.3× | 3.3k 1.2× | 16 | 18.7k | ||
| James H. Stein United States | 61 | 2.8k 0.6× | 3.0k 0.7× | 4.1k 1.1× | 7.6k 2.3× | 2.1k 0.8× | 345 | 18.2k |
Countries citing papers authored by John E. Hokanson
Since
Specialization
Citations
This map shows the geographic impact of John E. Hokanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Hokanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Hokanson more than expected).
Fields of papers citing papers by John E. Hokanson
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by John E. Hokanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Hokanson. The network helps show where John E. Hokanson may publish in the future.
Co-authorship network of co-authors of John E. Hokanson
This figure shows the co-authorship network connecting the top 25 collaborators of John E. Hokanson. A scholar is included among the top collaborators of John E. Hokanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Hokanson. John E. Hokanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Litkowski, Elizabeth, Mark W. Logue, Rui Zhang, et al.. (2023). Mendelian randomization study of diabetes and dementia in the Million Veteran Program. Alzheimer s & Dementia. 19(10). 4367–4376.
2.
Litkowski, Elizabeth, Mark W. Logue, Rui Zhang, et al.. (2022). A Diabetes Genetic Risk Score Is Associated With All-Cause Dementia and Clinically Diagnosed Vascular Dementia in the Million Veteran Program. Diabetes Care. 45(11). 2544–2552.
3.
Wan, Emily S., Craig P. Hersh, A. Schwartz, et al.. (2021). Inhaled Medication Use in Smokers With Normal Spirometry. Respiratory Care. 66(4). 652–660.
4.
Ragland, M.F., Erin Austin, Kendra A. Young, et al.. (2020). <p>Co-Morbidity Patterns Identified Using Latent Class Analysis of Medications Predict All-Cause Mortality Independent of Other Known Risk Factors: The COPDGene<sup>®</sup> Study</p>. Clinical Epidemiology. Volume 12. 1171–1181.
5.
Moll, Matthew, Elizabeth A. Regan, John E. Hokanson, et al.. (2020). The Association of Multiparity with Lung Function and Chronic Obstructive Pulmonary Disease-Related Phenotypes. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 7(2). 86–98.
6.
Kanter, Jenny E., Baohai Shao, Farah Kramer, et al.. (2019). Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes. Journal of Clinical Investigation. 129(10). 4165–4179.
7.
Wan, Emily S., Spyridon Fortis, Elizabeth A. Regan, et al.. (2018). Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study. American Journal of Respiratory and Critical Care Medicine. 198(11). 1397–1405.
8.
Bhatt, Surya P., Gonzalo Vegas‐Sánchez‐Ferrero, Farbod N. Rahaghi, et al.. (2017). Cardiac Morphometry on Computed Tomography and Exacerbation Reduction with β-Blocker Therapy in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 196(11). 1484–1488.
9.
Hartz, Sarah M., Amy C. Horton, Dana B. Hancock, et al.. (2017). Genetic correlation between smoking behaviors and schizophrenia. Schizophrenia Research. 194. 86–90.
10.
Estépar, Raúl San Jośe, Gregory L. Kinney, Jennifer L. Black‐Shinn, et al.. (2013). Computed Tomographic Measures of Pulmonary Vascular Morphology in Smokers and Their Clinical Implications. American Journal of Respiratory and Critical Care Medicine. 188(2). 231–239.
11.
Foreman, Marilyn G., Lening Zhang, James R. Murphy, et al.. (2011). Early-Onset Chronic Obstructive Pulmonary Disease Is Associated with Female Sex, Maternal Factors, and African American Race in the COPDGene Study. American Journal of Respiratory and Critical Care Medicine. 184(4). 414–420.
12.
Wan, Emily S., John E. Hokanson, James R. Murphy, et al.. (2011). Clinical and Radiographic Predictors of GOLD–Unclassified Smokers in the COPDGene Study. American Journal of Respiratory and Critical Care Medicine. 184(1). 57–63.
13.
Kinney, Gregory L., Janet K. Snell‐Bergeon, David M. Maahs, et al.. (2011). Lipoprotein-Associated Phospholipase A 2 Activity Predicts Progression of Subclinical Coronary Atherosclerosis. Diabetes Technology & Therapeutics. 13(3). 381–387.
14.
Castaldi, Peter J., Michael H. Cho, Augusto A. Litonjua, et al.. (2011). The Association of Genome-Wide Significant Spirometric Loci with Chronic Obstructive Pulmonary Disease Susceptibility. American Journal of Respiratory Cell and Molecular Biology. 45(6). 1147–1153.
15.
Arcaroli, John J., John E. Hokanson, Edward Abraham, et al.. (2008). Extracellular Superoxide Dismutase Haplotypes Are Associated with Acute Lung Injury and Mortality. American Journal of Respiratory and Critical Care Medicine. 179(2). 105–112.
16.
Pratte, Katherine, Anna E. Barón, Lorraine G. Ogden, et al.. (2008). Plasminogen activator inhibitor-1 is associated with coronary artery calcium in Type 1 diabetes. Journal of Diabetes and its Complications. 23(6). 387–393.
17.
Mehrotra, Rajnish, Matthew J. Budoff, John E. Hokanson, et al.. (2005). Progression of coronary artery calcification in diabetics with and without chronic kidney disease. Kidney International. 68(3). 1258–1266.
18.
Austin, Melissa A., John E. Hokanson, & Karen L. Edwards. (1998). Hypertriglyceridemia as a Cardiovascular Risk Factor. The American Journal of Cardiology. 81(4). 7B–12B.
19.
Marzetta, C A, John E. Hokanson, David M. Foster, & John D. Brunzell. (1987). Simultaneous analysis of structural and metabolic heterogeneity of human ldl using density gradient ultracentrifugation. Arteriosclerosis An Official Journal of the American Heart Association Inc. 7(5). 505–506.
20.
Chung, B H, Jere P. Segrest, Marjorie J. Ray, et al.. (1986). [8] Single vertical spin density gradient ultracentrifugation. Methods in enzymology on CD-ROM/Methods in enzymology. 128. 181–209.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Yaping Zhang Breakdown of academic impact, for papers by Ömer Toprak Breakdown of academic impact, for papers by Ziad A. Massy Breakdown of academic impact, for papers by Ian H. de Boer Breakdown of academic impact, for papers by Stephan J. L. Bakker Breakdown of academic impact, for papers by Paul E. de Jong Breakdown of academic impact, for papers by Rijk O. B. Gans Breakdown of academic impact, for papers by Cihat Şarkış Breakdown of academic impact, for papers by Hüseyin Kurt Breakdown of academic impact, for papers by James H. Stein